Covishield vaccine to cost Rs 400 per dose for states, Rs 600 for private hospitals: Serum Institute

Scroll Staff

· Apr 21, 2021 · 01:16 pm

Coronavirus: Covaxin neutralises double mutant strain, other variants, says ICMR

Scroll Staff

· Apr 21, 2021 · 09:35 am

Tamil actor Vivekh dies in Chennai at 59

Scroll Staff

· Apr 17, 2021 · 07:52 am

Tamil actor Vivekh hospitalised after suffering from cardiac arrest

Scroll Staff

· Apr 16, 2021 · 09:42 pm

Coronavirus: Haffkine Biopharma to produce Covaxin after Centre grants approval to Maharashtra

Scroll Staff

· Apr 16, 2021 · 08:08 am

Coronavirus: 320 doses of Covaxin missing from Jaipur hospital, FIR filed

Scroll Staff

· Apr 14, 2021 · 08:13 pm

Covid-19: At the current pace, India will need another 13 months to vaccinate 60% of the population

Shreya Raman, IndiaSpend.com Kriti Kapur, IndiaSpend.com

· Apr 14, 2021 · 01:30 pm

India is producing less than half of the 1 crore Covid-19 vaccine doses it needs every day

Govindraj Ethiraj, IndiaSpend.com

· Apr 12, 2021 · 01:30 pm

Should the government open up Covid-19 vaccinations for all?

Vijayta Lalwani Arunabh Saikia

· Apr 07, 2021 · 06:30 am

Coronavirus: Centre’s expert panel allows clinical trials of third dose of Covaxin

Scroll Staff

· Apr 02, 2021 · 02:46 pm

Brazil refuses permission to import Covaxin, Bharat Biotech says it will fulfil requirements

Scroll Staff

· Mar 31, 2021 · 08:38 pm

The big news: Mamata Banerjee appeals for peace after attack on her, and nine other top stories

Scroll Staff

· Mar 11, 2021 · 09:34 pm

A stark class divide is emerging in India’s Covid-19 vaccination drive

Vijayta Lalwani

· Mar 11, 2021 · 09:00 am

Bharat Biotech’s Covaxin can drop ‘clinical trial mode’ tag, no consent form needed anymore

Scroll Staff

· Mar 11, 2021 · 08:20 am

India is widening its Covid-19 vaccination drive, but without sharing data on adverse reactions

Anoo Bhuyan, IndiaSpend.com

· Mar 10, 2021 · 01:30 pm

Disclose your capacity to manufacture Covid vaccines, Delhi HC tells Serum Institute, Bharat Biotech

Scroll Staff

· Mar 04, 2021 · 03:06 pm

The big news: Bharat Biotech vaccine shows 81% efficacy in phase 3 trials, and 9 other top stories

Scroll Staff

· Mar 03, 2021 · 09:33 pm

Covaxin showed 81% efficacy in third phase trials, says Bharat Biotech

Scroll Staff

· Mar 03, 2021 · 05:14 pm

Indians who are waiting for a ‘better’ Covid-19 vaccine might be making a lethal mistake

Manavi Kapur, qz.com

· Mar 03, 2021 · 01:30 pm

When it comes to giving approval, India has different yardsticks for homegrown and foreign vaccines

Manavi Kapur, qz.com

· Mar 01, 2021 · 01:30 pm